Management of High Risk Prostate Cancer
Adam S. Kibel, MD, presents on high-risk prostate cancer management.
Read MoreSelect Page
Posted by Adam S. Kibel, MD | Feb 2025
Adam S. Kibel, MD, presents on high-risk prostate cancer management.
Read MorePosted by Amy Krambeck, MD | Feb 2025
Amy E. Krambeck, MD, explores the management of urolithiasis in pregnancy, emphasizing the challenges of diagnosis and treatment.
Read MorePosted by Arthur L. Burnett II, MD, MBA, FACS | Feb 2025
Arthur L. Burnett II, MD, MBA, FACS, reflects on over 30 years of research on priapism.
Read MorePosted by Sung Yong Cho, MD, MS, Phd | Feb 2025
Sung Youg Cho, MD, MS, PhD, explores single-use digital flexible ureteroscopes for endoscopic stone surgery.
Read MorePosted by David G. Bostwick, MD, MBA, FCAP | Feb 2025
David G. Bostwick, MD, MBA, FCAP, explores the role of artificial intelligence (AI) and digital pathology in advancing diagnostic accuracy in prostate cancer. In this 19-minute presentation, Dr. Bostwick addresses the limitations of using biopsies and radical prostatectomies as the gold standard in prostate cancer diagnosis. Despite its high initial costs and operational challenges, he emphasizes that digital pathology holds transformative potential for standardization and efficiency in pathology practices.
Dr. Bostwick delves into the long-standing application of AI in pathology, highlighting its ability to reduce human workloads. Advances in digital pathology have improved resolution, speed, and data transfer capabilities, enabling better integration of AI tools for detecting and grading cancer.
Dr. Bostwick asserts the future of pathology lies in 3D optical slicing and deep learning algorithms, which allow for precise tumor quantification and three-dimensional reconstructions of tissues. These methods could revolutionize grading systems, offering unparalleled accuracy and data granularity.
Read More